- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02069301
Evaluation of an Integrated Microfinance and Depression Care Program for Women (LIFE-DM)
Development of an Integrated Microfinance and Depression Care Program for Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Depression is one of the largest contributors to the world's health burden. Prior work in the Partners in Care study has shown that evidence-based service delivery programs for depression can improve health outcomes in depressed patients, and especially in minorities, largely overcoming disparities in outcomes from care between whites and minorities. Effective treatments exist, but they do not reach many depressed individuals, especially in resource-poor communities--ethnic minorities, rural residents in the United States, and individuals in most of the developing world.
Women, in particular, are at risk for depression and poverty. Integrating programs that treat depression and address livelihood concerns may improve engagement in depression treatment and improve mental health and functioning for patients in low-resource settings. The proposed study would integrate depression care with existing "microfinance" programs, which provide poverty-alleviation services including small loans, savings programs, and vocational training to women.
This project will (1) conduct qualitative studies of barriers and facilitators of women's successful use of existing depression care and microfinance programs; (2) adapt and integrate the depression care and microfinance services; (3) train Women's Union facilitators to deliver the integrated depression care and microfinance program; and conduct evaluation of LIFE-DM program to assess acceptability, feasibility, and preliminary effectiveness. The non-randomized control trial compares the integrated microfinance and collaborative care intervention with enhanced treatment as usual (national guideline antidepressant care and referral to microfinance resources) at the Women's Union in Danang city in Vietnam.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Da Nang, Vietnam
- Hoa Cuong Bac Commune Health Station
-
Da Nang, Vietnam
- Hoa Cuong Nam Commune Health Station
-
Da Nang, Vietnam
- Hoa Hiep Nam Commune Health Station
-
Da Nang, Vietnam
- Hoa Minh Commune Health Station
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- depression, low-income
Exclusion Criteria:
- psychosis, mania, substance abuse, high suicide risk, physical disabilities, significant cognitive impairments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Integrated Depression/Microfinance Group
LIFE-DM is a Depression and Microfinance integrated program using behavior activation and problem solving therapy applied to both depression and livelihood.
Livelihood support include microfinance loans, personal finance, and income-generation skills.
|
LIFE-DM Integrated Depression and Microfinance group, uses behavior activation and problem solving therapy skills to teach patients how to manage mood and reach livelihood goals.
Other Names:
National Guideline for antidepressant care
Other Names:
Livelihood support, including group-based loans to develop small enterprise, personal finance management education, business management skills, vocational training, and rotating-credit savings program.
Other Names:
|
|
Other: Treatment as Usual
Currently treatment as usual in this province includes national guidelines for antidepressant care for depression and referral for microfinance/livelihood programs
|
National Guideline for antidepressant care
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Depression Score from the Patient Health Questionnaire
Time Frame: 0, 6, 12 months
|
The PHQ-9 is a nine-item validated tool measuring depressive symptoms based on DSM-IV criteria.
The answers are rated on a scale from zero (not at all) to three (nearly every day).
Total scores range from 0-27, subdivided into five categories of depression severity: 1 to 4 is minimal; 5 to 9 is mild; 10 to 14 is moderate; 15 to 19 is moderate-severe; and 20 and above is severe.
The PHQ-9 has been widely used internationally including in Vietnam.
|
0, 6, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quality of Life Score from Quality of Life and Enjoyment and Satisfaction Questionnaire
Time Frame: 0, 6, 12 months
|
The Quality of Life Enjoyment and Satisfaction Questionnaire is a self-report measure designed to enable investigators to easily obtain sensitive measures of the degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning.
The summary scores were found to be reliable and valid measures of these dimensions in a group of depressed outpatients.
The Q-LES-Q measures were related to, but not redundant with, measures of overall severity of illness or severity of depression within this sample.
These findings suggest that the Q-LES-Q measures may be sensitive to important differences among depressed patients that are not detected by the measures usually employed.
|
0, 6, 12 months
|
|
Change in Self-Efficacy Score from Self Efficacy Survey
Time Frame: 0, 6, 12 months
|
Items were developed to assess effectiveness of a goal-setting and planning intervention (Macleod et al., 2008).
Self-efficacy is assessed via 4-items that measure locus of control, materials and skills to complete goals, confidence, and optimism.
Self-efficacy is rated on a 9-point scale from 1 ("Not at all") to 9 ("To a great extent").
|
0, 6, 12 months
|
|
Change in Social Support Index from Medical Outcome Study Social Support Survey
Time Frame: 0, 6, 12 months
|
A brief, multidimensional, selfadministered, social support survey that was developed for patients in the Medical Outcomes Study (MOS), a two-year study of patients with chronic conditions.
This survey was designed to be comprehensive in terms of recent thinking about the various dimensions of social support.
|
0, 6, 12 months
|
|
Change in health and mental health functioning scores from Medical Outcomes Study Short Form Health Survey (SF-12)
Time Frame: 0, 6, 12 months
|
The SF-12v2 is a 12-item survey that measures the same eight domains of health.
The domains scores are summarized into two composite scores: Physical Component Summary and Mental Component Summary scores.
The survey is a brief, reliable measure of overall health status.
It is useful in large population health surveys and has been used in Vietnamese populations.
|
0, 6, 12 months
|
|
Change in Anxiety Symptom Score from Generalized Anxiety Disorder (GAD-7) Scale
Time Frame: 0, 6, 12 months
|
The GAD-7 is a 7-item anxiety scale used for screening and assessing symptom severity of GAD.
GAD and depression symptoms frequently occurred together, but factor analysis confirmed them as distinct dimensions, and they had independent effects on functional impairment and disability.
Self-report and interviewer-administered versions of GAD-7 were in good agreement.
|
0, 6, 12 months
|
|
Change in Behavior Activation Score from the Behavior Activation for Depression Scale Short Form (BADS-SF)
Time Frame: 0, 6, 12 months
|
The abbreviated BADS-SF is a nine-item scale measuring factors expected to change as a function of behavioral activation, including activation and avoidance
|
0, 6, 12 months
|
|
Change in household wealth indicators from Economic Well-Being Inventory
Time Frame: 0, 6, 12 months
|
The economic well-being inventory collect various indicators of self-reported household wealth: housing materials, land ownership, home ownership, and selling and purchasing of assets such as livestock and durable goods (car, bicycle, radio, TV), as well as income, savings, and debt.
This economic well-being inventory was used in the Danang Household Mental Health Survey.
|
0, 6, 12 months
|
|
Change in number and type of income generating activities from the Employment and business Activities Questionnaire
Time Frame: 0, 6, 12 months
|
We developed questionnaire to measure income generating activities, which include questions about participation and number of hours in types of employment and income generating activities in Low-Income countries, including formal salaried employment, farming and planting food, selling goods and services, property rentals, etc.
|
0, 6, 12 months
|
|
Treatment Acceptability Score from Help-Seeking Behavior Questionnaire
Time Frame: 0, 6, 12 months
|
This measure consists of items that assesses 1) resources in the community, 2) participant's help seeking history, 3) perceived effectiveness, and 4) acceptability of a variety of strategies used for depression care.
|
0, 6, 12 months
|
|
Depression Stigma Score from the Depression Stigma Questionnaire
Time Frame: 0, 6, 12 months
|
18 item questionnaire about perceived and personal stigma related to depression.
|
0, 6, 12 months
|
|
Social Capital Score from Social Capital Assessment Tool
Time Frame: 0, 6, 12 months
|
The short version of the Adapted Social Capital Assessment Tool (SASCAT) is a nine-item tool measures the structural (quantity of social relationships) and cognitive (quality of social relationships) components of social capital as well as citizenship.
The measure derived from the Adapted Social Capital Assessment Tool (A-SCAT) (Harpham et al., 2002).
The measures has been used in many international settings, including developing countries.
|
0, 6, 12 months
|
|
Total Score Client Service Satisfaction Questionnaire
Time Frame: 0, 6, 12 months
|
A standardized measure with strong psychometric properties that could be used to assess general satisfaction across varied health and human services.
The CSQ Scales® (CSQ) measure may be used to assess client satisfaction with mental health services, as a program evaluation tool, or to assess client satisfaction within and across programs (intra- or inter-program) and demographic groups.
|
0, 6, 12 months
|
|
Number of Participants Demonstrating Mental Health Literacy with Depression Vignette
Time Frame: 0, 12 months
|
Vignette describes someone with the minimal number of symptoms necessary for major depression (according to DSM description).
Respondents were asked an open-ended question, ''What would you say, if anything, is wrong with Mary?''
Only answers including " depression " are considered a correct response.
|
0, 12 months
|
|
Number of Participants with Depression Diagnosis - MINI International Neuropsychiatric Interview, Version 6.0 (MINI)
Time Frame: 0, 6, 12 months
|
The MINI is a brief structured psychiatric interview used to diagnose for multiple axis I DSM-IV mental disorders.
In this study, the MINI is used to assess for major depressive episodes.
Using DSM-IV criteria (at least 5 symptoms of depression over a 2 week period; endorsement of depressed mood or anhedonia were necessary for diagnosis) the interviewers can distinguish between past, current, and recurrent episodes of depression.
The MINI is a reliable and valid alternative to the longer Structured Clinical Interview for Diagnostic.
The MINI has been used widely in developing countries and administered by non-mental health providers.
|
0, 6, 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Victoria K Ngo, PhD, RAND
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Mood Disorders
- Depression
- Depressive Disorder
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Psychotropic Drugs
- Serotonin Uptake Inhibitors
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Serotonin Agents
- Cytochrome P-450 Enzyme Inhibitors
- Antidepressive Agents, Second-Generation
- Cytochrome P-450 CYP2D6 Inhibitors
- Fluoxetine
- Antidepressive Agents
Other Study ID Numbers
- 5R34MH094648-02 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Integrated Depression/Microfinance Group
-
RANDGrand Challenges Canada; Danang Psychiatric Hospital; Basic Needs VietnamCompleted
-
Brown UniversityJohns Hopkins University; National Institute of Mental Health (NIMH); NYU Langone... and other collaboratorsCompletedHypertension | Diabetes | HIV/AIDS | Noncommunicable DiseasesKenya
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedMental Disorders | Multiple TraumaCongo
-
University of California, San FranciscoCompletedDepressionUnited States
-
Scott & White Health PlanCompletedChronic IllnessUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI); Icahn School of Medicine... and other collaboratorsCompletedCardiovascular Disease | DiabetesKenya
-
Sunnybrook Health Sciences CentreCompleted
-
Shanghai Mental Health CenterCompletedDrug Use Disorders | Addiction, DrugChina
-
Brown UniversityNational Institute of Mental Health (NIMH)CompletedEffectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major DepressionMajor Depressive DisorderUnited States
-
Oregon Research InstituteCompletedOverweight | Weight Loss | Adolescent Behavior | Family ResearchUnited States